SB 231 is a health care payment reform bill focused on value-based payment requirements. Based on the bill caption and legislative action, the measure appears to establish or revise rules governing how certain health care services, providers, insurers, or managed care arrangements are paid, with an emphasis on payment models tied to quality, outcomes, or performance rather than solely to volume of services. The bill was enacted and ultimately became effective ninety days after passage, indicating it moved through the Legislature as a completed statutory change rather than a proposal that stalled or was amended away.
The bill’s practical effect is to alter state law governing health care reimbursement arrangements, likely affecting insurers, health plans, provider networks, and other entities that contract for or administer value-based care. It may require compliance with new payment standards, reporting expectations, contract terms, or oversight provisions related to alternative payment models. Because the bill title is broad and the full text was not available in the provided materials, the precise statutory sections amended cannot be identified here, but the legislation clearly targets the legal framework for value-based payment in West Virginia’s health care system.
Impact
SB 231 likely amends West Virginia statutes governing health insurance, provider contracting, or health care payment policy by setting requirements for value-based payment arrangements. Its impact would fall primarily on insurers, health plans, hospitals, physicians, and other health care providers that participate in reimbursement models tied to quality or outcomes. The bill may also affect state regulators responsible for enforcing insurance and health care payment rules.
Sentiment
The available voting history suggests broad bipartisan support for SB 231. The bill passed the Senate unanimously, passed the House with a strong majority, and then received final concurrence in the Senate without opposition. That pattern indicates the measure was generally viewed favorably and did not generate major public disagreement in the recorded floor votes.
Contention
No committee transcript was provided, and the roll-call votes show little overt contention. The only notable resistance appears in the House vote, where seven members voted no on final passage, suggesting some concern about the details of the payment requirements, regulatory burden, or effects on providers and insurers. However, the absence of committee debate in the supplied record makes it impossible to identify the specific objections or the legislators who raised them.